GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Vivo Bio Tech Ltd

Vivo Bio Tech Board Approves Q2 FY27 Standalone & Consolidated Financial Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 11 Nov 2026, 07:16 PM IST  ·  BSE ID: 68fe5e09-9199-4235-8533-24c11cd603ee
View Original BSE Filing (PDF)
💡
In Simple Terms
Vivo Bio Tech's board approved and submitted its financial results for the quarter ending September 30, 2026.
🤖 AI Summary
  • Vivo Bio Tech Board approved Unaudited Standalone Financial Results for Q2 FY27 on November 11, 2026.
  • Board also approved Unaudited Consolidated Financial Results for the quarter ended September 30, 2026.
  • A Limited Review Report by M/s. P. Murali & Co., Chartered Accountants, was enclosed with the results.
  • The board meeting commenced at 06:30 p.m. and concluded at 07:00 p.m. on November 11, 2026.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this board meeting outcome.
👤
Who Is Affected
All shareholders are informed that the company has met its regulatory requirement to approve and submit its unaudited financial results for Q2 FY27.
🔍
Management Signal
Management is adhering to regulatory timelines by approving and submitting the unaudited financial results for the specified period.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Release of the detailed Q2 FY27 financial results by Vivo Bio Tech.
Review of the Limited Review Report from Statutory Auditors for Q2 FY27.
Management commentary or investor presentation following the results release.
LOW RISK This is a routine compliance filing reporting the approval of financial results.
💡 Investor Takeaway
Vivo Bio Tech Limited's Board of Directors approved Unaudited Standalone and Consolidated Financial Results for Q2 FY27 (quarter ended September 30, 2026) on November 11, 2026. This filing confirms the completion of regulatory reporting obligations.
📅 Company Track Record
Previous filing on July 13, 2026, reported Q1 FY27 consolidated net profit as Rs. 18.76 Lacs, a decrease of 85.95% YoY despite a 14.13% revenue growth for that period.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What financial period do these Vivo Bio Tech results cover?
The approved financial results cover the Second Quarter ended September 30, 2026, which corresponds to Q2 FY27.
When did Vivo Bio Tech's board approve the Q2 FY27 financial results?
Vivo Bio Tech's Board of Directors approved the Q2 FY27 financial results at their meeting held on Wednesday, November 11, 2026.
Which auditors reviewed Vivo Bio Tech's Q2 FY27 financial results?
The Unaudited Standalone & Consolidated Financial Results for Q2 FY27 included a Limited Review Report issued by the Statutory Auditors M/s. P. Murali & Co., Chartered Accountants.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.